Navigation Links
B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System

BETHLEHEM, Pa., July 14, 2011 /PRNewswire/ -- The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) announced today the availability of the Plasmat™ Futura System for H.E.L.P.®  LDL Apheresis therapy. This addition to B. Braun's existing H.E.L.P.® therapy provides a more easy-to-use system for clinicians to administer the most effective care to patients with severe hypercholesterolemia.


H.E.L.P.®  therapy (Heparin-induced Extracorporeal Lipoprotein Precipitation) is a blood cleansing procedure for the long-term management of patients with severe, congenital lipid disorders that cannot be adequately treated with diet modification or drugs.

"The addition of the Plasmat™ Futura Apheresis system to our existing H.E.L.P.® therapy system exemplifies B. Braun's commitment to providing clinicians with innovative systems that help get their jobs done with more convenience and flexibility," said Samuel Amory, Vice President, Medical Technology Division for B. Braun Medical Inc. "LDL Apheresis therapy is a complex therapy and the Plasmat™ Futura helps to streamline treatment."  

Designed to be compact and easy to use, the Plasmat™ Futura system provides built-in convenience for maximum mobility and flexibility. In addition, the Plasmat™ Futura features a state-of-the-art user interface and does not require an on-site water treatment system, both improvements over the previous H.E.L.P.® system.

"The Plasmat™ Futura LDL Apheresis machine is the first promising procedure that has drastically cut my LDL by more than 60 percent," said Patrika Wallach-Knickle, a patient of Massachusetts General Hospital. "All it requires is a commitment of two mornings a month to sit and relax while the machine does the work. This small commitment is nothing compared to the benefits of seeing my small child grow up. I am very grateful for the B. Braun Plasmat™ Futura LDL Apheresis machine."

For more information on the Plasmat™ Futura System for H.E.L.P.® Apheresis therapy or to request a demo please visit or call 800-848-2600.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at or visit B. Braun at

SOURCE B. Braun Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
2. B. Braun Awarded Contract With HealthTrust Purchasing Group to Provide Pain Management Solutions
3. B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings
4. MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical Treatment for Cardiovascular Disease
5. B. Braun Introduces WHIN(R) Safe Huber Needle
6. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
7. B. Braun Renal Therapies Division Announces Availability of Adimea
8. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
9. Health Robotics Re-Acquires CytoCares European Rights from B. Braun Melsungen AG for Undisclosed Consideration
10. New Technology Center Increases B. Brauns Infusion Pump Capacity
11. B. Braun Large Volume Heparin Infusion Solutions Now Available
Post Your Comments:
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the French ...
(Date:11/26/2015)... November 26, 2015 ... universitetssjukhus ser potential att använda SyMRI för ... för patienter med multipel skleros (MS) ... med SyntheticMR AB för att kunna använda ... sjukhuset. Med SyMRI kan man generera flera ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center ... reliability. , The new Q-Suite 6 platform is based on the latest Java Enterprise ... a specific piece of software for many key components of the suite. Much of ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... For the ... companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two groups ... to aid in MAP International’s cause. , MAP International was founded in 1954 and ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, the industry ... Wimbledon Athletics Facebook page to educate the public, parents and school athletic ... 2,000 people under the age of 25 die from sudden cardiac arrest every ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
Breaking Medicine News(10 mins):